Biodesix (BDSX) Other Operating Expenses (2019 - 2026)

Biodesix (BDSX) has reported Other Operating Expenses for 8 consecutive years, with $4.2 million the latest figure, recorded in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $4.2 million, up 11.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.5 million (down 117.86% YoY), and the FY2025 annual result was -$92.9 million, down 687.34% from the prior year.
• Other Operating Expenses was $4.2 million for Q1 2026 at Biodesix, up from -$23.9 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $78.0 million in Q4 2024 and troughed at -$23.9 million in Q4 2025.
• Average Other Operating Expenses over 5 years is $3.5 million, with a median of $3.4 million recorded in 2023.
• The widest YoY moves for Other Operating Expenses: up 2194.82% in 2024, down 758.45% in 2024.
• Over 5 years, Other Operating Expenses stood at $3.3 million in 2022, then gained by 2.78% to $3.4 million in 2023, then soared by 2194.82% to $78.0 million in 2024, then tumbled by 130.66% to -$23.9 million in 2025, then jumped by 117.61% to $4.2 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $4.2 million in Q1 2026, -$23.9 million in Q4 2025, and $4.1 million in Q3 2025.